FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 298:1213-1217 June 1, 1978 Number 22 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To assess long-term results, coronary and graft angiography was performed 53 to 84 months after operation in 22 of 30 consecutive patients who had undergone coronary-artery bypass grafting before 1973, and who had at least one graft patent at an early (three to nine months) postoperative study. Of the 33 grafts, 31 were patent at late study. All patients had severe symptoms before operation. Of 16 who became asymptomatic early after operation, angina pectoris later redeveloped in 11. Progression of disease in ungrafted vessels accounted for symptomatic deterioration in nine of these 11 patients. We conclude that most grafts patent several months after operation remain so for at least 4 1/2 years, and that although most patients improve symptomatically after operation, symptomatic deterioration is common in the succeeding years and is most often due to progression of disease in ungrafted vessels.

This article has been cited by other articles:

• Mehta, R. H., Bhatt, D. L., Steg, Ph. G., Goto, S., Hirsch, A. T., Liau, C.-S., Rother, J., Wilson, P. W.F., Richard, A.-J., Eagle, K. A., Ohman, E. M., on behalf of the REACH Registry Investigators, (2008). Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J 29: 3052-3060 [Abstract] [Full Text]  
• Choussat, R., Black, A. J. R., Bossi, I., Joseph, T., Fajadet, J., Marco, J. (2000). Long-term clinical outcome after endoluminal reconstruction of diffusely degenerated saphenous vein grafts with less-shortening wallstents. J Am Coll Cardiol 36: 387-394 [Abstract] [Full Text]  
• de Feyter, P.J. (2000). The fatal attraction of saphenous venous bypass grafts. Eur Heart J 21: 697-698  
• Bhargava, B., Kornowski, R., Mehran, R., Kent, K. M., Hong, M. K., Lansky, A. J., Waksman, R., Pichard, A. D., Satler, L. F., Leon, M. B. (2000). Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol 35: 389-397 [Abstract] [Full Text]  
• Rosenschein, U., Gaul, G., Erbel, R., Amann, F., Velasguez, D., Stoerger, H., Simon, R., Gomez, G., Troster, J., Bartorelli, A., Pieper, M., Kyriakides, Z., Laniado, S., Miller, H. I., Cribier, A., Fajadet, J. (1999). Percutaneous Transluminal Therapy of Occluded Saphenous Vein Grafts : Can the Challenge Be Met With Ultrasound Thrombolysis?. Circulation 99: 26-29 [Abstract] [Full Text]